Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Critical Care Management Following Lung Transplantation

  • Jeon, Kyeongman (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2022.07.15
  • Accepted : 2022.07.18
  • Published : 2022.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Postoperative critical care management for lung transplant recipients in the intensive care unit (ICU) has expanded in recent years due to its complexity and impact on clinical outcomes. The practical aspects of post-transplant critical care management, especially regarding ventilation and hemodynamic management during the early postoperative period in the ICU, are discussed in this brief review. Monitoring in the ICU provides information on the patient's clinical status, diagnostic assessment of complications, and future management plans since lung transplantation involves unique pathophysiological conditions and risk factors for complications. After lung transplantation, the grafts should be appropriately ventilated with lung protective strategies to prevent ventilator-induced lung injury, as well as to promote graft function and maintain adequate gas exchange. Hypotension and varying degrees of pulmonary edema are common in the immediate postoperative lung transplantation setting. Ventricular dysfunction in lung transplant recipients should also be considered. Therefore, adequate volume and hemodynamic management with vasoactive agents based on their physiological effects and patient response are critical in the early postoperative lung transplantation period. Integrated management provided by a professional multidisciplinary team is essential for the critical care management of lung transplant recipients in the ICU.

Keywords

Acknowledgement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References

  1. Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021;40:1349-79. https://doi.org/10.1016/j.healun.2021.07.005
  2. The National Institute of Organ, Tissue and Blood Management. Organ transplantation statistics [Internet]. Seoul: The National Institute of Organ, Tissue and Blood Management; 2020 [cited 2022 Jun 30]. Available from: https://www.konos.go.kr.
  3. Ko RE, Lee JG, Kim SY, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: analysis of Korean organ transplantation registry (KOTRY) data. Respir Res 2020;21:20. https://doi.org/10.1186/s12931-020-1289-2
  4. Fuehner T, Kuehn C, Welte T, Gottlieb J. ICU care before and after lung transplantation. Chest 2016;150:442-50. https://doi.org/10.1016/j.chest.2016.02.656
  5. Di Nardo M, Tikkanen J, Husain S, et al. Postoperative management of lung transplant recipients in the intensive care unit. Anesthesiology 2022;136:482-99. https://doi.org/10.1097/ALN.0000000000004054
  6. Kao CC, Parulekar AD. Postoperative management of lung transplant recipients. J Thorac Dis 2019;11(Suppl 14):S1782-8. https://doi.org/10.21037/jtd.2019.05.60
  7. Geube M, Anandamurthy B, Yared JP. Perioperative management of the lung graft following lung transplantation. Crit Care Clin 2019;35:27-43. https://doi.org/10.1016/j.ccc.2018.08.007
  8. Marczin N, de Waal EE, Hopkins PM, et al. International consensus recommendations for anesthetic and intensive care management of lung transplantation: an EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplant 2021;40:1327-48. https://doi.org/10.1016/j.healun.2021.07.012
  9. Schuurmans MM, Benden C, Inci I. Practical approach to early postoperative management of lung transplant recipients. Swiss Med Wkly 2013;143:w13773.
  10. Monchaud C, Marquet P. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I. Clin Pharmacokinet 2009;48:419-62. https://doi.org/10.2165/11317230-000000000-00000
  11. Monchaud C, Marquet P. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II. Clin Pharmacokinet 2009;48:489-516. https://doi.org/10.2165/11317240-000000000-00000
  12. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009;37(7 Suppl):S186-202. https://doi.org/10.1097/CCM.0b013e3181aa5241
  13. Geurts M, Macleod MR, Kollmar R, Kremer PH, van der Worp HB. Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med 2014;42:231-42. https://doi.org/10.1097/CCM.0b013e3182a276e8
  14. Potestio C, Jordan D, Kachulis B. Acute postoperative management after lung transplantation. Best Pract Res Clin Anaesthesiol 2017;31:273-84. https://doi.org/10.1016/j.bpa.2017.07.004
  15. Senoner T, Velik-Salchner C, Tauber H. The pulmonary artery catheter in the perioperative setting: should it still be used? Diagnostics (Basel) 2022;12:177. https://doi.org/10.3390/diagnostics12010177
  16. McRae KM. Pulmonary transplantation. Curr Opin Anaesthesiol 2000;13:53-9. https://doi.org/10.1097/00001503-200002000-00009
  17. Kusunose K, Tsutsui RS, Bhatt K, et al. Prognostic value of RV function before and after lung transplantation. JACC Cardiovasc Imaging 2014;7:1084-94. https://doi.org/10.1016/j.jcmg.2014.07.012
  18. Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol 1996;27:384-91.
  19. Moulton MJ, Creswell LL, Ungacta FF, Downing SW, Szabo BA, Pasque MK. Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension. Circulation 1996;94(9 Suppl):II312-9.
  20. Schulman LL, Leibowitz DW, Anandarangam T, et al. Variability of right ventricular functional recovery after lung transplantation. Transplantation 1996;62:622-5. https://doi.org/10.1097/00007890-199609150-00014
  21. Kasimir MT, Seebacher G, Jaksch P, et al. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 2004;26:776-81. https://doi.org/10.1016/j.ejcts.2004.05.057
  22. Beer A, Reed RM, Bolukbas S, et al. Mechanical ventilation after lung transplantation: an international survey of practices and preferences. Ann Am Thorac Soc 2014;11:546-53. https://doi.org/10.1513/AnnalsATS.201312-419OC
  23. King CS, Valentine V, Cattamanchi A, et al. Early postoperative management after lung transplantation: results of an international survey. Clin Transplant 2017;31:e12985. https://doi.org/10.1111/ctr.12985
  24. de Perrot M, Imai Y, Volgyesi GA, et al. Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model. J Thorac Cardiovasc Surg 2002;124:1137-44. https://doi.org/10.1067/mtc.2002.125056
  25. Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013;369:428-37. https://doi.org/10.1056/NEJMoa1301082
  26. Eberlein M, Reed RM, Bolukbas S, et al. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation. J Heart Lung Transplant 2015;34:233-40. https://doi.org/10.1016/j.healun.2014.09.030
  27. Dezube R, Arnaoutakis GJ, Reed RM, et al. The effect of lung-size mismatch on mechanical ventilation tidal volumes after bilateral lung transplantation. Interact Cardiovasc Thorac Surg 2013;16:275-81. https://doi.org/10.1093/icvts/ivs493
  28. Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015;372:747-55. https://doi.org/10.1056/NEJMsa1410639
  29. Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315:788-800. https://doi.org/10.1001/jama.2016.0291
  30. Tonetti T, Vasques F, Rapetti F, et al. Driving pressure and mechanical power: new targets for VILI prevention. Ann Transl Med 2017;5:286. https://doi.org/10.21037/atm.2017.07.08
  31. Ahn HJ, Park M, Kim JA, et al. Driving pressure guided ventilation. Korean J Anesthesiol 2020;73:194-204. https://doi.org/10.4097/kja.20041
  32. Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013;187:527-34. https://doi.org/10.1164/rccm.201210-1865OC
  33. Wang R, Pan C, Wang X, Xu F, Jiang S, Li M. The impact of tracheotomy timing in critically ill patients undergoing mechanical ventilation: a meta-analysis of randomized controlled clinical trials with trial sequential analysis. Heart Lung 2019;48:46-54. https://doi.org/10.1016/j.hrtlng.2018.09.005
  34. Meade MO, Granton JT, Matte-Martyn A, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med 2003;167:1483-9. https://doi.org/10.1164/rccm.2203034
  35. Perrin G, Roch A, Michelet P, et al. Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study. Chest 2006;129:1024-30. https://doi.org/10.1378/chest.129.4.1024
  36. Botha P, Jeyakanthan M, Rao JN, et al. Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 2007;26:1199-205. https://doi.org/10.1016/j.healun.2007.08.008
  37. Van Raemdonck D, Hartwig MG, Hertz MI, et al. Report of the ISHLT Working Group on primary lung graft dysfunction part IV: prevention and treatment: a 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017;36:1121-36. https://doi.org/10.1016/j.healun.2017.07.013
  38. Ghadimi K, Cappiello J, Cooter-Wright M, et al. Inhaled pulmonary vasodilator therapy in adult lung transplant: a randomized clinical trial. JAMA Surg 2022;157:e215856. https://doi.org/10.1001/jamasurg.2021.5856
  39. Hartwig MG, Walczak R, Lin SS, Davis RD. Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. Ann Thorac Surg 2012;93:366-71. https://doi.org/10.1016/j.athoracsur.2011.05.017
  40. Wigfield CH, Lindsey JD, Steffens TG, Edwards NM, Love RB. Early institution of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation improves outcome. J Heart Lung Transplant 2007;26:331-8. https://doi.org/10.1016/j.healun.2006.12.010
  41. Bellier J, Lhommet P, Bonnette P, et al. Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: long-term outcomes. Clin Transplant 2019;33:e13480. https://doi.org/10.1111/ctr.13480
  42. Na SJ, Jeon K. Extracorporeal membrane oxygenation support in adult patients with acute respiratory distress syndrome. Expert Rev Respir Med 2020;14:511-9. https://doi.org/10.1080/17476348.2020.1734457
  43. Fan E, Del Sorbo L, Goligher EC, et al. An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2017;195:1253-63. https://doi.org/10.1164/rccm.201703-0548ST
  44. Kaplan JD, Trulock EP, Cooper JD, Schuster DP. Pulmonary vascular permeability after lung transplantation: a positron emission tomographic study. Am Rev Respir Dis 1992;145(4 Pt 1):954-7. https://doi.org/10.1164/ajrccm/145.4_Pt_1.954
  45. Cui Y, Liu K, Lamattina AM, Visner G, El-Chemaly S. Lymphatic vessels: the next frontier in lung transplant. Ann Am Thorac Soc 2017;14(Supplement_3):S226-32. https://doi.org/10.1513/AnnalsATS.201606-465MG
  46. Currey J, Pilcher DV, Davies A, et al. Implementation of a management guideline aimed at minimizing the severity of primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg 2010;139:154-61. https://doi.org/10.1016/j.jtcvs.2009.08.031
  47. Pilcher DV, Scheinkestel CD, Snell GI, Davey-Quinn A, Bailey MJ, Williams TJ. High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation. J Thorac Cardiovasc Surg 2005;129:912-8. https://doi.org/10.1016/j.jtcvs.2004.07.006
  48. Mizota T, Fujiwara K, Hamada M, Matsukawa S, Segawa H. Effect of arginine vasopressin on systemic and pulmonary arterial pressure in a patient with pulmonary hypertension secondary to pulmonary emphysema: a case report. JA Clin Rep 2017;3:1. https://doi.org/10.1186/s40981-016-0072-3
  49. Legrand M, Zarbock A. Ten tips to optimize vasopressors use in the critically ill patient with hypotension. Intensive Care Med 2022;48:736-9. https://doi.org/10.1007/s00134-022-06708-y
  50. McIntyre WF, Um KJ, Alhazzani W, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA 2018;319:1889-900. https://doi.org/10.1001/jama.2018.4528
  51. Tudorache I, Sommer W, Kuhn C, et al. Lung transplantation for severe pulmonary hypertension: awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling. Transplantation 2015;99:451-8. https://doi.org/10.1097/TP.0000000000000348
  52. Hoeper MM, Benza RL, Corris P, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J 2019;53:1801906. https://doi.org/10.1183/13993003.01906-2018
  53. Hoetzenecker K, Schwarz S, Muckenhuber M, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. J Thorac Cardiovasc Surg 2018;155:2193-206. https://doi.org/10.1016/j.jtcvs.2017.10.144
  54. Moser B, Jaksch P, Taghavi S, et al. Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg 2018;53:178-85. https://doi.org/10.1093/ejcts/ezx212